These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 26856943

  • 1. Longitudinal associations between MRI and cognitive changes in very early MS.
    Nourbakhsh B, Nunan-Saah J, Maghzi AH, Julian LJ, Spain R, Jin C, Lazar A, Pelletier D, Waubant E.
    Mult Scler Relat Disord; 2016 Jan; 5():47-52. PubMed ID: 26856943
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal associations between brain structural changes and fatigue in early MS.
    Nourbakhsh B, Azevedo C, Nunan-Saah J, Maghzi AH, Spain R, Pelletier D, Waubant E.
    Mult Scler Relat Disord; 2016 Jan; 5():29-33. PubMed ID: 26856940
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis.
    Maghzi AH, Revirajan N, Julian LJ, Spain R, Mowry EM, Liu S, Jin C, Green AJ, McCulloch CE, Pelletier D, Waubant E.
    Mult Scler Relat Disord; 2014 Nov; 3(6):720-7. PubMed ID: 25891551
    [Abstract] [Full Text] [Related]

  • 4. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U, Bozzali M, Spanò B, Cercignani M, Serra L, Basile B, Mannu R, Caltagirone C, De Luca J.
    Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
    [Abstract] [Full Text] [Related]

  • 5. Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
    Nourbakhsh B, Azevedo C, Maghzi AH, Spain R, Pelletier D, Waubant E.
    J Neurol Sci; 2016 Jul 15; 366():229-233. PubMed ID: 27288812
    [Abstract] [Full Text] [Related]

  • 6. Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
    Granberg T, Martola J, Bergendal G, Shams S, Damangir S, Aspelin P, Fredrikson S, Kristoffersen-Wiberg M.
    Mult Scler; 2015 Aug 15; 21(9):1151-8. PubMed ID: 25480866
    [Abstract] [Full Text] [Related]

  • 7. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP, Portaccio E, Goretti B, Zipoli V, Battaglini M, Bartolozzi ML, Stromillo ML, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N.
    Arch Neurol; 2007 Aug 15; 64(8):1157-61. PubMed ID: 17698706
    [Abstract] [Full Text] [Related]

  • 8. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, De Stefano N.
    Neurology; 2008 Aug 26; 71(9):632-8. PubMed ID: 18725589
    [Abstract] [Full Text] [Related]

  • 9. Subclinical MRI disease activity influences cognitive performance in MS patients.
    Damasceno A, Damasceno BP, Cendes F.
    Mult Scler Relat Disord; 2015 Mar 26; 4(2):137-43. PubMed ID: 25787189
    [Abstract] [Full Text] [Related]

  • 10. Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.
    Pinter D, Khalil M, Pichler A, Langkammer C, Ropele S, Marschik PB, Fuchs S, Fazekas F, Enzinger C.
    Neuroimage Clin; 2015 Mar 26; 7():715-20. PubMed ID: 25844323
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings.
    Piras MR, Magnano I, Canu ED, Paulus KS, Satta WM, Soddu A, Conti M, Achene A, Solinas G, Aiello I.
    J Neurol Neurosurg Psychiatry; 2003 Jul 26; 74(7):878-85. PubMed ID: 12810771
    [Abstract] [Full Text] [Related]

  • 12. Fatigue and depression predict quality of life in patients with early multiple sclerosis: a longitudinal study.
    Nourbakhsh B, Julian L, Waubant E.
    Eur J Neurol; 2016 Sep 26; 23(9):1482-6. PubMed ID: 27416110
    [Abstract] [Full Text] [Related]

  • 13. Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
    Brochet B, Deloire MS, Bonnet M, Salort-Campana E, Ouallet JC, Petry KG, Dousset V.
    Mult Scler; 2008 Nov 26; 14(9):1242-9. PubMed ID: 18653737
    [Abstract] [Full Text] [Related]

  • 14. Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatment.
    Uher T, Benedict RH, Horakova D, Bergsland N, Dusankova JB, Tyblova M, Ramasamy DP, Seidl Z, Vaneckova M, Krasensky J, Havrdova E, Zivadinov R.
    J Neurol Sci; 2014 Dec 15; 347(1-2):229-34. PubMed ID: 25456460
    [Abstract] [Full Text] [Related]

  • 15. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A.
    J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420
    [Abstract] [Full Text] [Related]

  • 16. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep 15; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 17. Thalamic atrophy and cognition in multiple sclerosis.
    Houtchens MK, Benedict RH, Killiany R, Sharma J, Jaisani Z, Singh B, Weinstock-Guttman B, Guttmann CR, Bakshi R.
    Neurology; 2007 Sep 18; 69(12):1213-23. PubMed ID: 17875909
    [Abstract] [Full Text] [Related]

  • 18. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.
    Lazeron RH, Boringa JB, Schouten M, Uitdehaag BM, Bergers E, Lindeboom J, Eikelenboom MI, Scheltens PH, Barkhof F, Polman CH.
    Mult Scler; 2005 Oct 18; 11(5):524-31. PubMed ID: 16193889
    [Abstract] [Full Text] [Related]

  • 19. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K, Langdon D, Tubridy N, Hutchinson M, McGuigan C.
    Mult Scler Relat Disord; 2015 Nov 18; 4(6):521-5. PubMed ID: 26590658
    [Abstract] [Full Text] [Related]

  • 20. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.
    Neuroimage Clin; 2015 Nov 18; 8():440-7. PubMed ID: 26106524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.